Dr. Narjust Duma is a faculty member in the Division of Hematology, Medical Oncology, and Palliative Care. She is a medical oncologist with a clinical and research focus on thoracic malignancies. She has been recognized for her work with numerous awards, including the Mayo Brothers Distinguished Fellowship Award, considered the highest trainee honor in the Mayo Clinic School of Graduate Medical Education; the Merit Award/ASCO Employees Endowed Merit Award, American Society of Clinical Oncology; and the Next-Generation Innovators Award, HemOnc Today – Healio, Scholar in Training Award, 11th American Association of Cancer Research (AACR) conference on the science of cancer health disparities in racial/ethnic minorities and the medically underserved. Dr. Duma is a member of the National Hispanic Medical Association, the International Association for the study of the Lung Cancer (IASLC), the American Society of Clinical Oncology, Oncology Training Programs Committee, and the American Society of Clinical Oncology, Diversity and Inclusivity Task force.
Dr. Duma’s clinical interests include medical oncology with emphasis on thoracic cancer, including small cell and non-small cell lung cancer, thymic malignancies and mesothelioma. Her clinical interests includes the care of women with lung cancer including their unique aspects of cancer survivorship.
Dr. Duma’s clinical research focuses on lung cancer in women and cancer health disparities. She also conducts clinical research on the challenges and experiences during medical training by underrepresented groups in medicine and is an advocate and researcher in gender equity and balance in medicine.